InvestorsHub Logo
Followers 40
Posts 6183
Boards Moderated 1
Alias Born 04/10/2012

Re: conix post# 281780

Wednesday, 01/17/2018 12:15:24 PM

Wednesday, January 17, 2018 12:15:24 PM

Post# of 402216
Conix, just about every drug that Elite has ever gotten approved thus far and is currently selling are in markets that might be considered “peanuts”. There aren’t any multi-billion dollar products (or even several hundred million dollar products) that they have even gotten approved yet:

Hydromorphone 8mg tabs - $30M
Naltrexone 50mg tabs - $16M
Phentermine 37.5mg tabs - $40M
Isradipine 2.5 & 5.5mg tabs - $5.5M
Hydroxyzine 25 & 50mg tabs - $40M
Phendimetrazine 35mg tabs - $4.5M
Trimipramine 25/50/100mg tabs - $2M

Let’s be intellectually consistent here. Let them get a big ANDA approved and selling and THEN if they can’t penetrate that market in any meaningful way, your criticism will be justified.

Pending approval:

Oxycodone ADT - $2.3B
Hydro/APAP - $700M
Oxy/APAP - $700M
Undisclosed pain product - $40M







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News